Supplement

You have full text access to this OnlineOpen article

Guideline implementation for breast healthcare in low- and middle-income countries†

Diagnosis resource allocation

  1. Roman Shyyan MD, MSc1,‡,*,
  2. Stephen F. Sener MD2,3,
  3. Benjamin O. Anderson MD4,5,
  4. Leticia M. Fernández Garrote MD, PhD6,
  5. Gabriel N. Hortobágyi MD7,
  6. Julio A. Ibarra Jr. MD8,
  7. Britt-Marie Ljung MD9,
  8. Hélène Sancho-Garnier MD10,11,
  9. Helge Stalsberg MD12,
  10. on behalf of the Breast Health Global Initiative Diagnosis Panel §

Article first published online: 3 OCT 2008

DOI: 10.1002/cncr.23840

Issue

Cancer

Cancer

Supplement: Guidelines for International Breast Health and Cancer Control–Implementation

Volume 113, Issue Supplement 8, pages 2257–2268, 15 October 2008

Additional Information

How to Cite

Shyyan, R., Sener, S. F., Anderson, B. O., Fernández Garrote, L. M., Hortobágyi, G. N., Ibarra, J. A., Ljung, B.-M., Sancho-Garnier, H., Stalsberg, H. and on behalf of the Breast Health Global Initiative Diagnosis Panel (2008), Guideline implementation for breast healthcare in low- and middle-income countries. Cancer, 113: 2257–2268. doi: 10.1002/cncr.23840

Author Information

  1. 1

    Department of Surgery, Lviv Regional Cancer Center, Lviv, Ukraine

  2. 2

    Evanston Northwestern Healthcare, Evanston, Illinois

  3. 3

    Northwestern University Feinberg School of Medicine, Evanston, Illinois

  4. 4

    Department of Surgery, University of Washington, Seattle, Washington

  5. 5

    Division of Public Health Services, Fred Hutchinson Cancer Research Center, Seattle Washington

  6. 6

    National Oncology Institute, Havana, Cuba

  7. 7

    Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas

  8. 8

    Department of Pathology, Orange Coast Memorial Medical Center, Fountain Valley, California

  9. 9

    Department of Pathology, University of California at San Francisco, San Francisco, California

  10. 10

    International Union Against Cancer, Geneva, Switzerland

  11. 11

    Regional Cancer Center, Montpellier, France

  12. 12

    Department of Pathology, University Hospital of North Norway, Tromsø, Norway

  1. ‡

    Fax: (011) 380322953751

  2. §

    The Breast Health Global Initiative Diagnosis Panel members included Gaurav Agarwal; Justus Apffelstaedt; Nuran S. Bese; Maira Caleffi; R. F. Chinoy; Kathleen Errico; Leticia María Fernández Garrote; Gabriel N. Hortobagyi; Julio A. Ibarra, Jr.; Kardinah Britt-Marie Ljung; Mandar Nadkarni; Anthony Nsiah-Asare; Mary Onyango; Hélène Sancho-Garnier; Stephen F. Sener (Co-chair); Roman Shyyan (Co-chair); and László Vass.

*Department of Oncology, Lviv Regional Cancer Center, Hasheka Street 2a, 79031 Lviv, Ukraine

  1. †

    Complete financial disclosures are presented at the end of this article.

Publication History

  1. Issue published online: 3 OCT 2008
  2. Article first published online: 3 OCT 2008
  3. Manuscript Received: 10 JUN 2008
  4. Manuscript Accepted: 24 APR 2008

Funded by

  • The Breast Health Global Initiative Global Summit
  • AstraZeneca
  • Bristol-Myers Squibb Company
  • Ethicon Endo Surgery, Inc.
  • GE Healthcare
  • F. Hoffmann-La Roche AG
  • Novartis Oncology
  • Pfizer Inc.

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (388K)

REFERENCES

  • 1
    Anderson BO,Braun S,Lim S,Smith RA,Taplin S,Thomas DB. Early detection of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S51–S59.
    Direct Link:
  • 2
    Anderson BO,Braun S,Carlson RW, et al. Overview of breast health care guidelines for countries with limited resources. Breast J. 2003; 9( suppl 2): S42–S50.
    Direct Link:
  • 3
    Vargas HI,Anderson BO,Chopra R, et al. Diagnosis of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S60–S66.
    Direct Link:
  • 4
    Carlson RW,Anderson BO,Chopra R, et al. Treatment of breast cancer in countries with limited resources. Breast J. 2003; 9( suppl 2): S67–S74.
    Direct Link:
  • 5
    Anderson BO,Shyyan R,Eniu A, et al. Breast cancer in limited-resource countries: an overview of the Breast Health Global Initiative 2005 guidelines. Breast J. 2006; 12( suppl 1): S3–S15.
    Direct Link:
  • 6
    Smith RA,Caleffi M,Albert US, et al. Breast cancer in limited-resource countries: early detection and access to care. Breast J. 2006; 12( suppl 1): S16–S26.
    Direct Link:
  • 7
    Shyyan R,Masood S,Badwe RA, et al. Breast cancer in limited-resource countries: diagnosis and pathology. Breast J. 2006; 12( suppl 1): S27–S37.
    Direct Link:
  • 8
    Eniu A,Carlson RW,Aziz Z, et al. Breast cancer in limited-resource countries: treatment and allocation of resources. Breast J. 2006; 12( suppl 1): S38–S53.
    Direct Link:
  • 9
    Anderson BO,Yip CH,Ramsey SD, et al. Breast cancer in limited-resource countries: health care systems and public policy. Breast J. 2006; 12( suppl 1): S54–S69.
    Direct Link:
  • 10
    Gong Y,Symmans WF,Krishnamurthy S,Patel S,Sneige N. Optimal fixation conditions for immunocytochemical analysis of estrogen receptor in cytologic specimens of breast carcinoma. Cancer. 2004; 102: 34–40.
    Direct Link:
  • 11
    de Kanter AY,van Eijck CH,van Geel AN, et al. Multicentre study of ultrasonographically guided axillary node biopsy in patients with breast cancer. Br J Surg. 1999; 86: 1459–1462.
    Direct Link:
  • 12
    Sadowsky NL,Semine AA,Levin E,Kelly E. Ultrasonographic guidance for needle biopsy of breast lesions. Surg Oncol Clin North Am. 1997; 6: 265–284.
  • 13
    Singer CF,Kostler WJ,Hudelist G. Predicting the efficacy of trastuzumab-based therapy in breast cancer: current standards and future strategies. Biochim Biophys Acta. 2008 Mar 4. [Epub ahead of print]
  • 14
    Harford J,Azavedo E,Fischietto M. Breast health guideline implementation in low- and middle-income countries: health care system resource allocation. Cancer. 2008; 113( 8 suppl): 2282–2296.
    Direct Link:
  • 15
    Berg WA. Rationale for a trial of screening breast ultrasound: American College of Radiology Imaging Network (ACRIN) 6666. AJR Am J Roentgenol. 2003; 180: 1225–1228.
  • 16
    Fisher B,Anderson S,Bryant J, et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med. 2002; 347: 1233–1241.
  • 17
    Veronesi U,Cascinelli N,Mariani L, et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med. 2002; 347: 1227–1232.
  • 18
    Nadkarni MS,Gupta PB,Parmar VV,Badwe RA. Breast conservation surgery without preoperative mammography—a definite feasibility. Breast. 2006; 15: 595–600.
  • 19
    Collins LC,Connolly JL,Page DL, et al. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004; 28: 126–131.
  • 20
    Fahy BN,Bold RJ,Schneider PD,Khatri V,Goodnight JEJr. Cost-benefit analysis of biopsy methods for suspicious mammographic lesions. Arch Surg. 2001; 136: 990–994; discussion 994–995.
  • 21
    Brenner RJ,Bassett LW,Fajardo LL, et al. Stereotactic core needle breast biopsy: a multi-institutional prospective trial. Radiology. 2001; 218: 866–872.
  • 22
    Berner A,Davidson B,Sigstad E,Risberg B. Fine-needle aspiration cytology versus core biopsy in the diagnosis of breast lesions. Diagn Cytopathol. 2003; 29: 344–348.
    Direct Link:
  • 23
    Ljung BM,Drejet A,Chiampi N, et al. Diagnostic accuracy of fine-needle aspiration biopsy is determined by physician training in sampling technique. Cancer. 2001; 93: 263–268.
    Direct Link:
  • 24
    Crystal P,Koretz M,Shcharynsky S,Makarov V,Strano S. Accuracy of sonographically guided 14-gauge core-needle biopsy: results of 715 consecutive breast biopsies with at least 2-year follow-up of benign lesions. J Clin Ultrasound. 2005; 33: 47–52.
    Direct Link:
  • 25
    Crowe JPJr,Patrick RJ,Rybicki LA, et al. Does ultrasound core breast biopsy predict histologic finding on excisional biopsy? Am J Surg. 2003; 186: 397–399.
  • 26
    Ciatto S,Houssami N,Ambrogetti D, et al. Accuracy and underestimation of malignancy of breast core needle biopsy: the Florence experience of over 4000 consecutive biopsies. Breast Cancer Res Treat. 2007; 101: 291–297.
  • 27
    Masood S,Vass L,Ibarra JA, et al. Implementation of breast pathology guidelines for countries of limited resources. Cancer. 2008; 113( 8 suppl); 2297–2304.
    Direct Link:
  • 28
    MacDonald HR,Silverstein MJ,Mabry H, et al. Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins. Am J Surg. 2005; 190: 521–525.
  • 29
    Mai KT,Perkins DG,Mirsky D. Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic 3-dimensional view. Breast J. 2003; 9: 33–38.
    Direct Link:
  • 30
    Silverstein MJ. The University of Southern California/Van Nuys Prognostic Index For ductal carcinoma in situ of the breast. Am J Surg. 2003; 186: 337–343.
  • 31
    Payne SJ,Bowen RL,Jones JL,Wells CA. Predictive markers in breast cancer—the present. Histopathology. 2008; 52: 82–90.
    Direct Link:
  • 32
    Cui X,Schiff R,Arpino G,Osborne CK,Lee AV. Biology of progesterone receptor loss in breast cancer and its implications for endocrine therapy. J Clin Oncol. 2005; 23: 7721–7735.
  • 33
    Blamey RW,Cataliotti L. EUSOMA accreditation of breast units. Eur J Cancer. 2006; 42: 1331–1337.
  • 34
    Ellis IO,Humphreys S,Michell M,Pinder SE,Wells CA,Zakhour HD. Best Practice No. 179. Guidelines for breast needle core biopsy handling and reporting in breast screening assessment. J Clin Pathol. 2004; 57: 897–902.
View Full Article (HTML) Get PDF (388K)